Table 3.
Recipient\Donor | CC | CT | TT | Total |
---|---|---|---|---|
CC | 0/9 (0%) | 4/25 (16%) | 0/3 (0%) | 4/37(11%) |
CT | 4/25(16%) | 11/42 (42%) | 1/4 (25%) | 16/71 (23%) |
TT | 1/6 (17%) | 5/18(28%) | 1/3(33%) | 7/27 (26%) |
Total | 5/40(13%) | 20/85 (24%) | 2/10(20%) | 27/135 (20%) |
SVR, Sustained Viral Response
Odd ratio for development of cirrhosis in non-CC recipients vs. CC recipients, adjusted for donor IL28B genotype, was 2.61, (95% CI 0.83–8.22, p=0.10). Odd ratio for development of cirrhosis in non-cc donors vs. cc donors, adjusted for recipient IL-28B genotype was 2.28, (95% CI 0.79 -6.59, p=0.13).